Anti-BPIA2/ BPIFA2/ C20orf70 functional antibody

Anti-BPIA2/ BPIFA2/ C20orf70 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to BPIFA2/BPIFA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0691-Ab-1/ GM-Tg-hg-SE0691-Ab-2Anti-Human BPIFA2 monoclonal antibodyHuman
GM-Tg-rg-SE0691-Ab-1/ GM-Tg-rg-SE0691-Ab-2Anti-Rat BPIFA2 monoclonal antibodyRat
GM-Tg-mg-SE0691-Ab-1/ GM-Tg-mg-SE0691-Ab-2Anti-Mouse BPIFA2 monoclonal antibodyMouse
GM-Tg-cynog-SE0691-Ab-1/ GM-Tg-cynog-SE0691-Ab-2Anti-Cynomolgus/ Rhesus macaque BPIFA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0691-Ab-1/ GM-Tg-felg-SE0691-Ab-2Anti-Feline BPIFA2 monoclonal antibodyFeline
GM-Tg-cang-SE0691-Ab-1/ GM-Tg-cang-SE0691-Ab-2Anti-Canine BPIFA2 monoclonal antibodyCanine
GM-Tg-bovg-SE0691-Ab-1/ GM-Tg-bovg-SE0691-Ab-2Anti-Bovine BPIFA2 monoclonal antibodyBovine
GM-Tg-equg-SE0691-Ab-1/ GM-Tg-equg-SE0691-Ab-2Anti-Equine BPIFA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0691-Ab-1/ GM-Tg-hg-SE0691-Ab-2; GM-Tg-rg-SE0691-Ab-1/ GM-Tg-rg-SE0691-Ab-2;
GM-Tg-mg-SE0691-Ab-1/ GM-Tg-mg-SE0691-Ab-2; GM-Tg-cynog-SE0691-Ab-1/ GM-Tg-cynog-SE0691-Ab-2;
GM-Tg-felg-SE0691-Ab-1/ GM-Tg-felg-SE0691-Ab-2; GM-Tg-cang-SE0691-Ab-1/ GM-Tg-cang-SE0691-Ab-2;
GM-Tg-bovg-SE0691-Ab-1/ GM-Tg-bovg-SE0691-Ab-2; GM-Tg-equg-SE0691-Ab-1/ GM-Tg-equg-SE0691-Ab-2
Products NameAnti-BPIFA2 monoclonal antibody
Formatmab
Target NameBPIFA2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BPIFA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0691-Ag-1Recombinant multi-species BPIA2/ BPIFA2/ C20orf70 protein


    Target information

    Target IDGM-SE0691
    Target NameBPIFA2
    Gene ID140683,19194,50585,710376,608599,101099708
    Gene Symbol and SynonymsbA49G10.1,BPIFA2,Bpifa2e,C20orf70,PSP,SPLUNC2
    Uniprot AccessionQ96DR5,Q63471
    Uniprot Entry NameBPIA2_HUMAN,BPIA2_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000131050
    Target ClassificationN/A

    The target: BPIFA2, gene name: BPIFA2, also named as C20orf70, PSP, SPLUNC2, bA49G10.1. This gene encodes a member of the palate, lung and nasal epithelium clone (Plunc) family of proteins. Members of this family have been proposed to play a role in the local antibacterial response in nose, mouth and upper respiratory pathways. The encoded soluble salivary protein binds bacterial lipopolysaccharide (LPS) and inhibits bacterial growth. This gene is present in a gene cluster on chromosome 20. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.